Skip Standard Navigation Links
Centers for Disease Control and Prevention
 CDC Home Search Health Topics A-Z
peer-reviewed.gif (582 bytes)
eid_header.gif (2942 bytes)
 EID Home | Ahead of Print | Past Issues | EID Search | Contact Us | Announcements | Suggested Citation | Submit Manuscript

Volume 11, Number 1, January 2005

HEPA/Vaccine Plan for Indoor Anthrax Remediation

Lawrence M. Wein,* Yifan Liu,* and Terrance J. Leighton†
*Stanford University, Stanford, California, USA; and †Children's Hospital Oakland Research Institute, Oakland, California, USA

 
 
Figure 5.
  Back to article
 

Figure 5. The horizontal axes in these 4 plots give the original room deposition level before remediation begins. These plots show how the total number of anthrax cases (the stars and the left vertical axes) are distributed across room deposition levels, e.g., in plot A, most of the anthrax cases occur in rooms with original deposition levels >100 spores/m2. Similarly, the 2 curves and the right vertical axis of each plot show how much time is spent cleaning and sampling in rooms of various deposition levels. These 4 plots are identical except that the spore concentration threshold in spores/m2 (), which dictates when remediation is stopped, is A)  = 0.1; B)  = 1; C)  = 10; D)  = 100. These plots motivate the hybrid policy, which fumigates heavily contaminated rooms and uses the HEPA/vaccine approach in lightly contaminated rooms.

 

EID Home | Top of Page | Ahead-of-Print | Past Issues | Suggested Citation | EID Search | Contact Us | Accessibility | Privacy Policy Notice | CDC Home | CDC Search | Health Topics A-Z

This page last reviewed December 21, 2004

Emerging Infectious Diseases Journal
National Center for Infectious Diseases
Centers for Disease Control and Prevention